MXPA02006029A - Lipopeptidos novedosos como agentes antibacterianos. - Google Patents

Lipopeptidos novedosos como agentes antibacterianos.

Info

Publication number
MXPA02006029A
MXPA02006029A MXPA02006029A MXPA02006029A MXPA02006029A MX PA02006029 A MXPA02006029 A MX PA02006029A MX PA02006029 A MXPA02006029 A MX PA02006029A MX PA02006029 A MXPA02006029 A MX PA02006029A MX PA02006029 A MXPA02006029 A MX PA02006029A
Authority
MX
Mexico
Prior art keywords
compounds
antibacterial agents
novel
novel lipopeptides
relates
Prior art date
Application number
MXPA02006029A
Other languages
English (en)
Spanish (es)
Inventor
Michael Morytko
Original Assignee
Cubist Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cubist Pharm Inc filed Critical Cubist Pharm Inc
Publication of MXPA02006029A publication Critical patent/MXPA02006029A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MXPA02006029A 1999-12-15 2000-12-15 Lipopeptidos novedosos como agentes antibacterianos. MXPA02006029A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17094399P 1999-12-15 1999-12-15
PCT/US2000/034118 WO2001044272A2 (en) 1999-12-15 2000-12-15 Daptomycin analogs as antibacterial agents

Publications (1)

Publication Number Publication Date
MXPA02006029A true MXPA02006029A (es) 2004-08-23

Family

ID=22621910

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02006029A MXPA02006029A (es) 1999-12-15 2000-12-15 Lipopeptidos novedosos como agentes antibacterianos.

Country Status (13)

Country Link
US (2) US6911525B2 (cg-RX-API-DMAC10.html)
EP (4) EP1240181A2 (cg-RX-API-DMAC10.html)
JP (2) JP4990456B2 (cg-RX-API-DMAC10.html)
KR (1) KR20020063227A (cg-RX-API-DMAC10.html)
CN (1) CN1425025A (cg-RX-API-DMAC10.html)
AU (1) AU784755B2 (cg-RX-API-DMAC10.html)
BR (1) BR0017026A (cg-RX-API-DMAC10.html)
CA (1) CA2393907A1 (cg-RX-API-DMAC10.html)
IL (2) IL150223A0 (cg-RX-API-DMAC10.html)
MX (1) MXPA02006029A (cg-RX-API-DMAC10.html)
NO (1) NO20022888L (cg-RX-API-DMAC10.html)
WO (1) WO2001044272A2 (cg-RX-API-DMAC10.html)
ZA (1) ZA200205106B (cg-RX-API-DMAC10.html)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020063228A (ko) * 1999-12-15 2002-08-01 큐비스트 파마슈티컬즈 인코포레이티드 항균제로서 리포펩티드
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
CA2301336A1 (en) * 2000-03-17 2001-09-17 Michael T. Kelly Topical treatment of rosacea
CA2432096A1 (en) 2000-12-18 2002-08-01 Cubist Pharmaceuticals, Inc. Methods for preparing purified lipopeptides
US20060014674A1 (en) 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
ATE430160T1 (de) * 2001-08-06 2009-05-15 Cubist Pharm Inc Lipopeptid-stereoisomere, verfahren zu ihrer herstellung und nützliche zwischenprodukte
EP1932853A1 (en) 2001-08-06 2008-06-18 Cubist Pharmaceutical Inc. Novel depsipeptides and process for preparing same
ATE298758T1 (de) * 2001-08-28 2005-07-15 Pharmacia Corp Kristalline freie base von clindamycin
US6767718B2 (en) 2002-05-10 2004-07-27 Biosource Pharm, Inc. Lipodepsipeptide antibiotics and methods of preparation
EP1531828A4 (en) * 2002-05-23 2005-11-02 Activbiotics Inc METHODS OF TREATING BACTERIAL INFECTIONS AND ASSOCIATED DISEASES
WO2003103699A1 (en) 2002-06-06 2003-12-18 Vicuron Pharmaceuticals Inc. Use of ramoplanin to treat diseases associated with the use of antibiotics
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
ITMI20022076A1 (it) * 2002-10-01 2004-04-02 Antibioticos Spa Sali di intermedi del cefdinir.
US20040132764A1 (en) * 2002-10-23 2004-07-08 Morphochem Aktiengesellschaft Fuer Kombinatorische Chemie Antibiotics for the treatment of infections in acidic environments
US20060004185A1 (en) 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
US20080051326A1 (en) * 2004-11-12 2008-02-28 Alexander Dylan C Antiinfective Lipopeptides
CA2587848A1 (en) * 2004-11-12 2006-10-19 Cubist Pharmaceuticals, Inc. Antiinfective lipopeptides
NZ563271A (en) * 2005-04-29 2009-12-24 Cubist Pharm Inc Therapeutic compositions
WO2007127218A2 (en) * 2006-04-26 2007-11-08 Taro Pharmaceuticals U.S.A., Inc. Streptomyces-derived antimicrobial compound and method of using same against antibiotic-resistant bacteria
JP5345532B2 (ja) * 2006-08-02 2013-11-20 ヨハネス・グーテンベルク−ウニヴェルジテート・マインツ Ｌｃｔ中毒に対する医薬品
US8584854B2 (en) * 2007-02-06 2013-11-19 BBK Tobacco & Foods, LLP Reclosable package with magnetic clasp and detachable tray for rolling papers used in smoking articles
US20080185010A1 (en) * 2007-02-06 2008-08-07 Kesselman Joshua D Interleaved Transparent Cellulose Paper with Opaque Adhesive
US8662086B2 (en) 2007-02-06 2014-03-04 BBK Tobacco & Foods, LLP Reclosable package with magnetic clasp for rolling papers used in smoking articles
US20090020443A1 (en) * 2007-05-09 2009-01-22 Kesselman Joshua D Credit Card Carrying Pack for Rolling Papers
US9072319B2 (en) 2007-06-15 2015-07-07 Joshua D. Kesselman Rolling paper structures for creating smoking articles and gummed, coiled inserts for same
US9161572B2 (en) * 2007-06-15 2015-10-20 Bbk Tobacco & Foods, Inc. Structures for creating smoking articles and methods of packaging same
US20090014342A1 (en) * 2007-07-14 2009-01-15 Kesselman Joshua D Rolling papers and methods of packaging same
EP2018864A1 (en) 2007-07-23 2009-01-28 Biomet Deutschland GmbH Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition
CN101959849A (zh) * 2007-12-26 2011-01-26 利德治疗公司 作为抗菌剂的新型半合成糖肽
USD606858S1 (en) 2008-08-21 2009-12-29 Joshua Kesselman Packaging for smoking articles
US8393332B2 (en) 2008-08-21 2013-03-12 BBK Tobacco & Foods, LLP Packaging for rolling papers for smoking articles
GB2465863A (en) * 2008-12-05 2010-06-09 Lead Therapeutics Inc Semi-synthetic heptapeptidic glycopeptides for the treatment of bacterial infections
NZ594019A (en) * 2008-12-22 2013-08-30 Cubist Pharm Inc Novel antibacterial agents for the treatment of gram positive infections
AR074874A1 (es) 2008-12-23 2011-02-16 Biosource Pharm Inc Composiciones antibioticas para el tratamiento de infecciones gram negativas. metodo. uso. compuesto.
ES2374779B1 (es) * 2010-03-10 2012-12-27 Universidad De Barcelona Compuestos péptidicos útiles como agentes antibacterianos.
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
CA2806362A1 (en) * 2010-07-23 2012-01-26 Activbiotics Pharma, Llc Administration of rifalazil to immunocompromised patients
US10072045B1 (en) 2017-06-26 2018-09-11 Ramapo Pharmaceuticals, Inc. Antibacterial lipopeptides and methods for their preparation and use
US10526343B2 (en) 2018-03-26 2020-01-07 University Of Sharjah Heterocyclic systems and pharmaceutical applications thereof
CN110577581A (zh) * 2018-06-07 2019-12-17 美国蓝博药业公司 一种新型的抑菌脂肽化合物、制备方法及其应用
CN109182563B (zh) * 2018-08-01 2020-07-14 浙江大学 检测20种dfrA类甲氧苄胺嘧啶类药物耐药基因的方法及所用试剂盒
CN113061164B (zh) * 2021-03-29 2023-01-10 四川大学 环脂肽类化合物及其在抗类风湿关节炎药物中的应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
USRE32455E (en) 1978-10-16 1987-07-07 Eli Lilly And Company A-21978 antibiotics and process for their production
USRE32333E (en) 1978-10-16 1987-01-20 Eli Lilly And Company A-21978 Antibiotics and process for their production
DE3376424D1 (en) 1982-02-27 1988-06-01 Beecham Group Plc Antibacterial 1-normon-2-yl-heterocyclic compounds
US4482487A (en) 1982-05-21 1984-11-13 Eli Lilly And Company A-21978C cyclic peptides
US4524135A (en) 1982-05-21 1985-06-18 Eli Lilly And Company A-21978C cyclic peptides
US4396543A (en) 1982-05-21 1983-08-02 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4399067A (en) 1982-05-21 1983-08-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4537717A (en) 1982-05-21 1985-08-27 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
USRE32310E (en) 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
IL68700A0 (en) * 1982-05-21 1983-09-30 Lilly Co Eli Improvements relating to a-21978c cyclic peptide derivatives and their production
USRE32311E (en) 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4452775A (en) 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
US4885243A (en) 1984-10-09 1989-12-05 Eli Lilly And Company Process for producing A-21978C derivatives
ATE67788T1 (de) 1984-10-09 1991-10-15 Lilly Co Eli Herstellung von derivaten von a-21978c.
CA1315229C (en) 1987-06-10 1993-03-30 Patrick J. Baker Chromatographic purification process
US4874843A (en) 1987-12-03 1989-10-17 Eli Lilly And Company Chromatographic purification process
ATE140728T1 (de) 1990-06-07 1996-08-15 Lilly Co Eli Lipopeptid deacylase
JPH04167172A (ja) 1990-10-31 1992-06-15 Nec Corp ベクトルプロセッサ
WO1995005384A1 (en) 1993-08-13 1995-02-23 Smithkline Beecham Plc Derivatives of monic acids a and c having antibacterial, antimycoplasmatical, antifungal and herbicidal activity
DE4411025A1 (de) 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
ES2327981T3 (es) 1996-03-08 2009-11-05 Astellas Pharma Inc. Procedimiento para la desacilacion de lipopeptidos ciclicos.
DE19807972A1 (de) 1998-02-25 1999-08-26 Hoechst Marion Roussel De Gmbh Lipopeptidantibiotika-Calciumsalze, Verfahren zu ihrer Herstellung und Verwendung
US6468967B1 (en) 1998-09-25 2002-10-22 Cubist Pharmaceuticals, Incorporated Methods for administration of antibiotics
US9393093B2 (en) 2008-02-18 2016-07-19 Covidien Lp Clip for implant deployment device

Also Published As

Publication number Publication date
KR20020063227A (ko) 2002-08-01
WO2001044272A2 (en) 2001-06-21
CN1425025A (zh) 2003-06-18
US20050203006A1 (en) 2005-09-15
CA2393907A1 (en) 2001-06-21
ZA200205106B (en) 2003-09-25
WO2001044272A3 (en) 2001-11-29
US6911525B2 (en) 2005-06-28
JP2003517004A (ja) 2003-05-20
NO20022888L (no) 2002-08-02
EP1240181A2 (en) 2002-09-18
JP4990456B2 (ja) 2012-08-01
EP2298790A1 (en) 2011-03-23
EP1884520A2 (en) 2008-02-06
IL150223A0 (en) 2002-12-01
BR0017026A (pt) 2003-01-07
EP2295444A3 (en) 2011-03-23
US20020025924A1 (en) 2002-02-28
EP2295444A2 (en) 2011-03-16
IL150223A (en) 2013-09-30
AU2268201A (en) 2001-06-25
US7335725B2 (en) 2008-02-26
EP1884520A3 (en) 2008-03-05
JP2012140432A (ja) 2012-07-26
NO20022888D0 (no) 2002-06-17
AU784755B2 (en) 2006-06-08

Similar Documents

Publication Publication Date Title
MXPA02006029A (es) Lipopeptidos novedosos como agentes antibacterianos.
MXPA02006030A (es) Lipopeptidos como agentes antibacterianos.
MXPA02006028A (es) Lipopeptidos novedosos como agentes antibacterianos.
AU2002319814A1 (en) Substituted 1h-dihydropyrazoles, their preparation and use
EE200100487A (et) Uudsed ühendid ja kompositsioonid proteaasiinhibiitoritena
AU2002353775A1 (en) Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
DE60038183D1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
PL358281A1 (en) Novel compounds
MXPA02007942A (es) Derivados de pirrolopirimidinona, procesos de preparacion y uso.
MXPA03007857A (es) Compuestos y composiciones para entregar agentes activos.
AU3227700A (en) Skin sanitizing compositions
PL360254A1 (en) Pharmaceutical compositions
DE60033649D1 (de) Verbindungen und therapeutische methoden
SE9901077D0 (sv) Novel use
DE50113345D1 (de) Arginin-mimetika als faktor xa-inhibitoren
MXPA02010458A (es) Peptido modulador del receptor de trombopoyetina.
AU4011300A (en) Compositions and methods for the treatment of immune related diseases
PT1427417E (pt) Derivados de 6, 7-di-hidroxitetra-hidroisoquinolina substituída em 3 para utilização como agentes antibacterianos
PL328225A1 (en) Diphenylstilbenes as pro-medications used to produce cox-2-inhibitors
EP1303300A4 (en) COMPOSITIONS AND METHODS FOR TREATING CANDIDIASIS
IL150979A0 (en) 9-alkylamino-1-nitroacridine derivatives
AU7079300A (en) Compositions and methods for the treatment of immune related diseases
DE60212101D1 (de) Alanin-2,6-dialkoxyphenylesterderivate als hypnotika
MXPA05003633A (es) 2"-oxo-voruscharina y derivados de la misma.
SE9902147D0 (sv) Nya föreningar och farmaceutiska kompositioner innehållande desamma